Clinical Trials About "Global Mechanical Venous Thrombectomy Market Research Report Forecast" RSS

05:57 EDT 21st October 2018 | BioPortfolio

We list hundreds of Clinical Trials about "Global Mechanical Venous Thrombectomy Market Research Report Forecast" on BioPortfolio. We draw our references from global clinical trials data listed on and refresh our database daily.

More Information about "Global Mechanical Venous Thrombectomy Market Research Report Forecast" on BioPortfolio

We have published hundreds of Global Mechanical Venous Thrombectomy Market Research Report Forecast news stories on BioPortfolio along with dozens of Global Mechanical Venous Thrombectomy Market Research Report Forecast Clinical Trials and PubMed Articles about Global Mechanical Venous Thrombectomy Market Research Report Forecast for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Global Mechanical Venous Thrombectomy Market Research Report Forecast Companies in our database. You can also find out about relevant Global Mechanical Venous Thrombectomy Market Research Report Forecast Drugs and Medications on this site too.

Showing "Global Mechanical Venous Thrombectomy Market Research Report Forecast" Clinical Trials 1–25 of 15,000+

Extremely Relevant

Outcome of Percutaneous Mechanical Thrombectomy to Treat Acute Deep Venous Thrombosis

The purpose of this study was to compare the efficacy of Percutaneous mechanical thrombectomy (PMT) followed by standard anticoagulant therapy, with anticoagulation therapy alone, for the treatment of acute proximal lower extremity deep vein thrombosis.

Which Factors Influence the Duration and the Success of Mechanical Thrombectomy During the Acute Phase of Cerebral Infarction?

This study aims to identify factors influencing the time span and success of reperfusion after a mechanical thrombectomy in the acute phase of cerebral infarction, and in particular the effect of intra-venous thrombolysis.

Mechanical Thrombectomy

To determine the safety and efficacy of the Indigo Aspiration System for aspiration mechanical thrombectomy in patients with acute submassive pulmonary embolism (PE)

Short-duration Selective Brain Cooling for Patients Undergoing Mechanical Thrombectomy

To determine the efficacy and safety of short-duration intra-artery selective brain cooling in addition to mechanical thrombectomy in patients with acute ischemic stroke.

Stroke Cincinnati Prehospital Stroke Severity Scale Evaluation iN prEhospital

The effectiveness of acute ischemic stroke (AIS) management has improved considerably in recent years with thrombolysis and more recently with mechanical thrombectomy (MT). Currently, mechanical thrombectomy can only be performed in stroke unit with an interventional neuroradiology center by experienced/qualified interventional neuroradiologists. In the Rhone area, only one hospital has the authorization to perform mechanical thrombectomy. Therefore, transferring directly eligi...

Case Review of the Penumbra and Indigo Systems for Mechanical Thrombectomy in the Periphery

The primary objective of this retrospective case review study is to determine the safety and effectiveness of the Penumbra and Indigo Systems for mechanical thrombectomy in a cohort of patients with confirmed peripheral or visceral arterial occlusion or embolus. This is a retrospective, single arm, multi-center trial. Up to 100 patients at up to 10 centers will be enrolled. Angiographic assessment of vessel patency at immediate post-procedure as measured by TIMI scores and proc...


RNA Sequencing Analysis in Large Vessel Occlusion Stroke DATA Bank

Introduction: the source of embolic stroke , in thrombotic embolism , is of unknown origin in 30-40% of cases. Fortunately , Mechanical thrombectomy provide a direct method to retrieve the stroke-incriminated clots from stroke patients for possibility of exo-autopsy analysis.

Catheter Thrombectomy in Patients With Massive Pulmonary Embolism

Official Title: Compassionate Use of Catheter Thrombectomy (Aspirex 11F) in Patients With Massive Pulmonary Embolism Study Population: Patients >/= 18 years of age with massive pulmonary embolism suitable for mechanical thrombectomy with Aspirex 11F. Treatment: Aspirex 11F assisted thrombectomy _________ The study was terminated early. After having treated seven (7) patients, it was decided in April 2007 that the handling characteristics of the test device shoul...

Ideal Sedation for Stroke Thrombectomy

The Ideal Sedation for Stroke Thrombectomy (ISST) registry will answer the key questions whether sedation with intubation and paralytics is feasible and whether it delays the time to recanalization in comparison with conscious sedation alone. As a pilot registry, it is anticipated to enroll 40 acute stroke patients requiring mechanical thrombectomy over 12-18 months. Following enrollment, data will be collected prospectively from medical records and from patients' visits.

SEdation Versus General Anesthesia for Endovascular Therapy in Acute Ischemic Stroke

Objectives: This study aims to assess if the use of general anesthesia (GA) or sedation (CS) in patients with acute stroke undergoing intra-arterial mechanical thrombectomy, leads to better neurological outcomes and less peri-procedural complications. Hypothesis Null Hypothesis: There are no differences in outcomes in patients with acute stroke treated by intra-arterial mechanical thrombectomy using General anesthesia or Sedation.

FRench Acute Cerebral Multimodal Imaging to Select Patient for MEchanical Thrombectomy

FRench Acute cerebral multimodal imaging to select patient for MEchanical thrombectomy is a prospective multi-center study to determine if multimodal imaging could identify patients who may and those who may not benefit from an endovascular clot removal procedure within 6 hours after stroke onset.

Efficacy and Safety of Thrombectomy in Stroke With Extended Lesion and Extended Time Window

TENSION (Efficacy and safety of ThrombEctomy iN Stroke with extended leSION and extended time window) is a prospective, open label, blinded endpoint (PROBE), European two-arm, randomized, controlled, post-market study to compare the safety and effectiveness of endovascular thrombectomy as compared to best medical care alone in the treatment of acute ischemic stroke patients with extended stroke lesions defined by an Alberta Stroke Program Early CT Score (ASPECTS) score of 3-5 a...

Registry for Evaluating Outcome of Acute Ischemic Stroke Patients Treated With Mechanical Thrombectomy.

The Bernese-European RegistrY for ischemic stroke patients treated Outside current guidelines with Neurothrombectomy Devices using the SOLITAIRE™ FR With the Intention For Thrombectomy (BEYOND-SWIFT) is a retrospective, multi-center, non-randomized observational study aims to investigate the safety and efficacy of a Medtronic market-released neurothrombectomy device (applied as initial devices used for intervention) in acute ischemic stroke patients who do not fulfill treatme...

Perfusion Imaging Evaluation for Ischemic Stroke on 6-24 Hours Undergoing Endovascular Thrombectomy

This study aims to evaluate the hypothesis that thrombectomy devices plus medical management leads to superior clinical outcomes in acute ischemic stroke patients at 90 days as compared to medical management alone in appropriately selected subjects with the Target Mismatch Profile and an MCA (M1 and M2 segment) or ICA occlusion or BA who have endovascular thrombectomy initiated between 6-24 hours after last seen well.

The Venous Thrombus Extraction (VETEX) Clinical Study: A Preliminary Investigation

This is an open label, prospective, non-randomised, multi-centre first-in-human evaluation of the Vetex Thrombectomy Device for treatment of acute iliofemoral deep vein thrombosis (DVT)

Bridging Thrombolysis Versus Direct Mechanical Thrombectomy in Acute Ischemic Stroke

Intravenous thrombolysis with recombinant tissue-type plasminogen activator (IV t-PA) has been the only proven therapy for acute ischemic stroke (AIS) for almost 20 years. Whether IV t-PA prior to endovascular clot retrieval is beneficial for AIS patients with a proximal vessel occlusion in the anterior circulation has currently become a matter of debate and is a relevant unanswered question in clinical practice. The main objective is to determine whether subjects experiencing...

Cryo AF Global Registry

Cryo AF Global Registry a prospective, global, multi-center, observational Post-Market Registry

The Indigo System in Acute Lower Limb Malperfusion

To evaluate, in a controlled setting, the early safety and effectiveness of the Penumbra/Indigo aspiration thrombectomy Systems (San Francisco, California), and to define optimal technique for the use of these systems in patients with confirmed peripheral acute occlusions.

A Communication Skills Package to Prevent Fear of Cancer Recurrence

This study (FORECAST 2) builds upon the work of the successful pilot study (FORECAST) that found some evidence that breast cancer patients' fears of cancer recurrence (FCR) were sensitive to the communication exchange with therapeutic radiographers during weekly review appointments. The aim of FORECAST 2 is to co-design and pilot a communication training package for therapeutic radiographers to help them manage emotional talk with breast cancer patients who are undergoing treat...

COmparing CeNters ThRombectomy Aspiration STentretriever

Our aims is to evaluate the equality in efficacy and safety between direct aspiration technique and stent retriever thrombectomy procedure in anterior circulation strokes in a multicenter, prospective study.

Long Term Clinical Efficacy of Thrombectomy Devices in Acute ST Elevation Myocardial Infarction

Available data from randomized trials on thrombectomy in patients with ST-elevation myocardial infarction have shown favourable trends on myocardial reperfusion. Better myocardial reperfusion may translate in better late clinical outcome. However, only few data are available on the impact of thrombectomy on long term clinical outcome. Thus, the investigators designed a collaborative individual patient-data pooled-analysis aimed to assess the long-term clinical outcome in STEMI...

SOLITAIRE™ FR With the Intention For Thrombectomy (SWIFT) Study

The purpose of this study is to demonstrate substantial equivalence of the SOLITAIRE™ FR Revascularization Device (SOLITAIRE™ Device) with a legally marketed device, MERCI Retrieval System® (MERCI® Device). The study will demonstrate safety and efficacy of the SOLITAIRE™ Device in subjects requiring mechanical thrombectomy diagnosed with acute ischemic stroke.

Angiojet Rheolytic Thrombectomy in Case of Massive Pulmonary Embolism

This pilot study is mainly aimed to evaluate the feasibility and safety of the percutaneous Angiojet Rheolytic Thrombectomy (ART) in patients presenting a MPE. Secondarily the effectiveness of this treatment modality will also be estimated.

Post‐Market Registry Of Stroke Patients Treated With Medtronic Neuro Thrombectomy Devices to Collect Real World Data in South East Asia

The purpose of this post-market registry is to collect real-world data associated with the use of Medtronic market-released neurothrombectomy devices in acute ischemic stroke (AIS) patients from countries in South East Asia.

Predictive Factors of Outcome of Mechanical Thrombectomy After Acute Ischemic Stroke

Predictive factors of outcome of mechanical thrombectomy after acute ischemic stroke

More From BioPortfolio on "Global Mechanical Venous Thrombectomy Market Research Report Forecast"

Quick Search